← The Wire
AVIRNasdaq
Atea Pharmaceuticals, Inc.
Pharmaceutical Preparations · MA · CIK 1593899
Develops and commercializes novel, orally administered antivirals for serious viral diseases like hepatitis C and E
$359M
Market cap
$4.61
Last close
+2.7%
1D
+5.0%
5D
516K
Volume
Price · last 39 sessions-19.1%
May 4L $4.10 · H $5.70Jun 29
98
Total filings
Jun 22, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 22, 202610-Q10-QMay 12, 20268-KResults of OperationsMay 12, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 202610-K10-KMar 5, 20268-KResults of OperationsMar 5, 20268-KResults of OperationsJan 8, 202610-Q10-QNov 12, 20258-KResults of OperationsNov 12, 202510-Q10-QAug 7, 20258-KResults of OperationsAug 7, 20258-KShareholder VoteJun 20, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 2025DEF 14ADEF 14AApr 29, 20258-KExecutive Change · Material AgreementApr 17, 2025DEFA14ADEFA14AApr 3, 2025DEFA14ADEFA14AApr 1, 20258-KCompany UpdateApr 1, 2025DEFA14ADEFA14AMar 26, 2025DEFA14ADEFA14AMar 24, 20258-KCompany UpdateMar 24, 202510-K10-KMar 6, 20258-KResults of OperationsMar 6, 20258-KExecutive ChangeFeb 24, 20258-KResults of OperationsJan 14, 202510-Q10-QNov 7, 20248-KResults of OperationsNov 7, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KShareholder VoteJun 21, 2024DEFA14ADEFA14AJun 4, 202410-Q10-QMay 14, 20248-KResults of OperationsMay 14, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 202410-K10-KFeb 28, 20248-KResults of OperationsFeb 28, 2024SC 13GSC 13GFeb 7, 202410-Q10-QNov 8, 20238-KResults of OperationsNov 8, 2023SC 13GSC 13GOct 2, 202310-Q10-QAug 8, 20238-KResults of OperationsAug 8, 20238-KBylaw Amendment · Shareholder VoteJun 21, 2023DEFA14ADEFA14AJun 12, 2023DEFA14ADEFA14AMay 25, 2023SC 13DSC 13DMay 22, 202310-Q10-QMay 8, 20238-KResults of OperationsMay 8, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 202310-K10-KFeb 28, 20238-KResults of OperationsFeb 28, 202310-Q10-QNov 7, 20228-KResults of OperationsNov 7, 202210-Q10-QAug 8, 20228-KResults of OperationsAug 8, 20228-KShareholder VoteJun 21, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AApr 29, 2022DEF 14ADEF 14AApr 29, 202210-K10-KFeb 28, 20228-KResults of OperationsFeb 28, 2022SC 13GSCHEDULE 13GFeb 9, 2022SC 13GSC 13GFeb 4, 20228-KReg FD DisclosureJan 10, 2022SC 13GSC 13GDec 10, 20218-KReg FD DisclosureNov 26, 20218-KAgreement TerminatedNov 16, 202110-Q10-QNov 12, 20218-KResults of OperationsNov 12, 202110-Q10-QAug 12, 20218-KResults of OperationsAug 12, 20218-KMaterial Agreement · New Debt / ObligationJul 23, 20218-KShareholder VoteJun 21, 20218-KExecutive ChangeMay 20, 2021DEFA14ADEFA14AMay 20, 2021
Similar companies
Comparable business profile · signals at a glance